Income Statement (SEOUL/PHARMA)

getty Seoul-based Illimis Therapeutics has raised 58 billion won ($42 million) to fund its research into treatments for Alzheimers disease and expand into immune diseases. The Series B was led by K… [+2782 chars]...

Tokyo, Japan and Cambridge, UK, 4 July 2025 Nxera Pharma Co., Ltd. (Nxera or the Company; TSE 4565) today announces that it will receive US$4.8 million in milestone payments from Centessa Pharmaceuti… [+3676 chars]...

Mitsui & Co. (OTCMKTS:MITSY – Get Free Report) and Constellium (NYSE:CSTM – Get Free Report) are both industrials companies, but which is the better stock? We will compare the two companies based… [+6483 chars]...

Dublin, June 20, 2025 (GLOBE NEWSWIRE) -- The "Infectious Vaccine Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensi… [+6262 chars]...

Mitsui & Co. (OTCMKTS:MITSY – Get Free Report) and Constellium (NYSE:CSTM – Get Free Report) are both industrials companies, but which is the superior stock? We will contrast the two businesses b… [+6403 chars]...

Chicago, July 14, 2025 (GLOBE NEWSWIRE) -- The global automated immunoassay analyzers market was valued at US$ 23.12 billion in 2024 and is expected to reach US$ 74.59 billion by 2033, growing at a C… [+16342 chars]...